Show Notes
On June 6, Psymposia reported on the presenter contract for MAPS' Psychedelic Science 2023. The contract includes clauses that limit when and where presenters can speak, and a "MAPS Reputation" clause that warns speakers to not "tarnish" the organization's "reputation and goodwill." After our reporting, MAPS announced that all presenters would be released from the radius clause of the contract. Concerns with the "MAPS reputation" clause were not acknowledged. We also discuss Russell Hausfeld's reporting on Kentucky's recent decision to use opioid settlement money on ibogaine research.
Read more:
Psychedelic Science 2023 Contract Muzzles Speakers: Two Clauses Dictate What Presenters Can and Can't Say by Russell Hausfeld
$42M for psychedelics research is not how Kentucky should be fighting opioid addiction by Russell Hausfeld
State of Kentucky Sets aside $42 Million for Psychedelic Research, with Focus on Ibogaine by Psychedelic Alpha
The Ibogaine Conversation by Psymposia
Support the show:
☼Patreon: http://patreon.com/psymposia ☼Donate: https://www.psymposia.com/donate/
Follow:
☼Twitter: https://twitter.com/psymposia ☼Instagram: https://www.instagram.com/psymposia/ ☼Facebook: https://www.facebook.com/psymposia ☼Website: https://www.psymposia.com ☼Podcast: https://www.psymposia.com/plusthree ☼Newsletter: https://www.psymposia.com/subscribe/
More from The Psymposia Podcast
Normie, Mike, and Neşe discuss the upcoming MAHA Summit and its psychedelic pharmaceutical sponsors.
The crew discusses the FDA's September 14 psychedelic hearing, including Neşe's experience being in attendance, the financial conflicts of interest at the event, and the pseudoscientific beliefs of practitioners who gave testimony. Footnotes: Submit written comment to the FDA by October 5, 2026 https://www.federalregister.gov/documents/2026/07/14/2026-14155/considerations-for-potential-future-therapeutic-use-of-psychedelic-drugs-public-hearing-request-for
Psymposia dives into the recent Rolling Stone article — "Reggie Watts Is a Prominent Ketamine Advocate. Was It His Ex's 'Undoing'?" — and explores how the dynamics at play in that article are pervasive within the psychedelic advocacy scene. Footnotes: Reggie Watts Is a Prominent Ketamine Advocate. Was It His Ex's 'Undoing'? (Rolling Stone): https://www.rollingstone.com/tv-movies/tv-movie-features/reggie-watts-ketamine-drug-advocate-1235607828/ Ending The Silence Around Psychedelic Therapy Abuse (Mad In America): https://www.madinamerica.com/2021/09/ending-silence-psychedelic-therapy-abuse/ Cover Story: Power Trip (Psymposia): https://www.psymposia.com/powertrip-2/ The Psychedelic Syndicate (Psymposia): https://www.psymposia.com/psychedelic-syndicate-executive-summary-silicon-valley-maps-lykos-mdma-fda-billionaires/index.html
Psymposia interviews YouTube documentarian @Alex-Novell about his experience with Andrew Callaghan and Channel 5, drug legalization, and creating documentary films. Thumbnail terminator image provided by Alex Novell.
Psymposia discusses takeaways from their "Psychedelic Conversion Therapy" series and reflects on the ten year anniversary of their "Coming Out of the Psychedelic Closet" series.